IgniteData has announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) and AstraZeneca to launch its innovative Archer tool for Electronic Health Record (EHR)-to-Electronic Data ...

The Lancet research papers build on the WHO’s Guidance for best practices in clinical trials released in September 2024.

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

Andrew Mackinnon, Executive GM, Medable, discusses how AI-driven innovations are streamlining clinical trials through ...

Failure to manage these regulatory complexities can result in spiralling development costs, lengthy delays, and siloed data. All of these can have an enormous impact on trial budgets and schedules. To ...

Keros plans on engaging with regulatory authorities, starting in the third quarter of 2025. Subject to the outcome of these regulatory interactions, Keros expects to initiate a Phase 2 clinical trial ...

Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.

The first clinical trial of a generative AI therapy bot suggests it was as effective as human therapy for people with ...